Postoperative Pain Management Market Outlook, Sales, Revenue, Industry Players

Posted by Aniket Ankushrao on May 29th, 2019

Post-operative pain management refers to a set of drugs and therapies used to minimize tissue and muscle spasm in the patient. This is particularly helpful for the patients who have undergone surgery. The increase in number of surgery across the globe is a primary factor behind the rapid growth of the global postoperative pain management market.

Read Report Summary: https://www.transparencymarketresearch.com/postoperative-pain-management-market.html

FDA has released several standard for the manufacturing of abuse-deterrent opioids in the U.S. This is expected to help manufacturer clarify FDA regulation easily. This could offer a boost to the postoperative pain management market. Introduction of non-opioid drugs with higher ability to relief patients from postoperative pain for a longer period of time. This is expected to increase the adoption of postoperative pain management drugs in the market. This is expected to fuel the global postoperative pain management market in the coming years.

Apart from the above, some of the prominent players operating in the postoperative pain management market are Novartis AG, Allergan plc.,Pfizer Inc., Mylan N.V., Purdue Pharma L.P, Endo International plc., Janssen Pharmaceuticals, Inc.,  Pacira Pharmaceuticals Inc., Egalet Corporation., and GlaxoSmithKline Plc. 

The global postoperative pain management market is rising at a significant pace and this is mainly because of the continuously growing population and increasing awareness about surgical treatments in cancer and other chronic diseases. These are expected is expected to impel demand in the postoperative pain management market. 

Apart from this, factors like changing healthcare scenario and growing awareness about postsurgical pain and trauma is expected to boost the global postoperative pain management market. 

As per a recent data released by WHO, it is estimated that nearly 234.2 million surgical procedures were performed in 2014.  And among them, approximately around 60-70% have complained of moderate to severe pain just after 24 hours of surgery. All these patients required to be treated with postoperative pain management drugs. 

Further, there is a significant rise in number of patients undergoing surgical procedures in the last few years.  Patients who underwent undergone surgery require the administration of postoperative pain management drugs within 24 hours of the surgical procedure to reduce moderate to severe postoperative pain. This has led to spur in the demand for postoperative pain management drugs in the global market.  

Lastly, favorable FDA regulation in the U.S. has helped manufacturers develop advanced opioids with abuse-deterrent properties. Several pharmaceutical companies are incorporating abuse-deterrent technologies to manufacture pain management drugs with novel formulations that are safe for consumption by patients without harmful side effects. The continuously developing abuse deterrent formulation, which offers the manufacturer an edge in postoperative pain management market is likely to propel the postoperative pain management market.

Read Report ToC: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=65381

On the basis of region, North America is expected to hold a major share in the global postoperative pain management market. This is mainly because of a surge in number of surgeries in the region. Furthermore, presence of key manufacturers in the region is another factor behind the growth of the postoperative pain management market.